Por qué reducir los tiempos dentro del hospital

URIBE C, JIMÉNEZ I, MORA M, ARANA A, SÁNCHEZ J, ZULUAGA L, ET AL. Epidemiology of cerebrovascular diseases in Sabaneta, Colombia (1992-1993). Rev Neurol. 1997;25:1008-12.

SILVA F, ARENAS W, ZARRUK W, RESTREPO J, BERNAL O, RAMÍREZ S, ET AL. Factores asociados al tiempo de consulta en pacientes con enfermedad cerebrovascular isquémica. Rev Neurol. 2007;44:259-64.

GROUP. TNIoNDaSr-PSS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-7.

HACKE W, KASTE M, BLUHMKI E, BROZMAN M, DÁVALOS A, GUIDETTI D, ET AL. ECASS Investigators. Thrombolysis with Alteplase 3 to 4.5 hours after Acute Ischemic Stroke. N Engl J Med. 2008;359(13):1317-29.

BERKHEMER OA, FRANSEN PSS, BEUMER D, VAN DEN BERG LA, LINGSMA HF, YOO AJ, ET AL. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. N Engl J Med. 2015;372(1):11-20.

SAVER JL, GOYAL M, BONAFE A, DIENER H-C, LEVY EI, PEREIRA VM, ET AL. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. N Engl J Med. 0(0):null.

CAMPBELL BCV, MITCHELL PJ, KLEINIG TJ, DEWEY HM, CHURILOV L, YASSI N, ET AL. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. N Engl J Med. 2015;372(11):1009-18.

GOYAL M, DEMCHUK AM, MENON BK, EESA M, REMPEL JL, THORNTON J, ET AL. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med. 2015;372(11):1019-30.

FASSBENDER K, BALUCANI C, WALTER S, LEVINE SR, HAASS A, GROTTA J. Streamlining of prehospital stroke management: the golden hour. The Lancet Neurology 12(6):585-96.

SAVER JL, STARKMAN S, ECKSTEIN M, STRATTON SJ, PRATT FD, HAMILTON S, ET AL. Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke. N Engl J Med. 2015;372(6):528-36.

LÓPEZ N, GARCÍA A, SÁNCHEZ J, LLORENS P, ÁLVAREZ M, PAMPLIEGA A, ET AL. Retraso extrahospitalario e intrahospitalario en el tratamiento del ictus. Revista Neurología 2005;40:531-6.

FONAROW GC, ZHAO X, SMITH EE, ET AL. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014;311(16):1632-40.

JAUCH EC, SAVER JL, ADAMS HP, BRUNO A, CONNORS JJ, DEMAERSCHALK BM, ET AL. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2013;44:870-947.